CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 471851754
- Phone
- 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- 4 Grant or award Director acquired 4,790 shares (grant or award)
- 4 Grant or award Director acquired 4,790 shares (grant or award)
- 8-K Event Shareholder vote results
- 4 Planned sale President and CEO sold 15,000 shares at $15.81 ($237,222)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale President and CEO sold 15,000 shares at $18.19 ($272,871)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Option exercise Chief Financial Officer acquired 20,041 shares (option exercise)
- 4 Planned sale President and CEO sold 15,000 shares at $21.86 ($327,942)
- 8-K Event Other events
- 424B5 Offering Prospectus
- 4 Planned sale Chief Medical Officer sold 12,878 shares at $28.36 ($365,220)
- FWP Offering Free Writing Prospectus
- 424B5 Offering Prospectus
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 10 of 41 · 806 filings